Peak6 Investments LLC Guardant Health, Inc. Call Options Transaction History

Peak6 Investments LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 10, 2023	BUY	$25.44 - $59.78 $404,496 - $950,502	15,900 Added 43.8%	52,200 $1.42 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $633,070 - $884,500	-14,500 Reduced 28.54%	36,300 $1.95 Million
Q2 2022 Aug 12, 2022	BUY	$28.82 - $77.35 $982,762 - $2.64 Million	34,100 Added 204.19%	50,800 $2.05 Million
Q1 2022 May 13, 2022	SELL	$48.25 - $100.49 $4.77 Million - $9.94 Million	-98,900 Reduced 85.55%	16,700 $1.11 Million
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $385,203 - $515,462	3,900 Added 3.49%	115,600 $14.5 Million
Q2 2021 Aug 13, 2021	SELL	$109.77 - $165.68 $461,034 - $695,856	-4,200 Reduced 3.62%	111,700 $13.9 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $14.6 Million - $20.5 Million	114,700 Added 9558.33%	115,900 $17.7 Million
Q4 2019 Feb 13, 2020	SELL	$59.49 - $82.78 $11,898 - $16,556	-200 Reduced 14.29%	1,200 $94,000
Q3 2019 Nov 08, 2019	SELL	$62.59 - $110.3 $757,339 - $1.33 Million	-12,100 Reduced 89.63%	1,400 $89,000
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $863,190 - $1.23 Million	13,500 New	13,500 $1.17 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.